References
- ColvinRBChronic allograft nephropathyN Engl J Med20033492288229014668453
- WaliRKMohanlalVRamosEEarly withdrawal of calcineurin inhibitors and rescue immunosuppression with sirolimus-based therapy in renal transplant recipients with moderate to severe renal dysfunctionAm J Transplant200771572158317511682
- Meier-KriescheHUScholdJDKaplanBLong-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies?Am J Transplant200441289129515268730
- AfzaliBTaylorALGoldsmithDJWhat we CAN do about chronic allograft nephropathy: role of immunosuppressive modulationsKidney Int2005682429244316316321
- MjörnstedtLSørensenSSvon zur MühlenBImproved renal function after early conversion from a calcineurin inhibitor to everolimus: a randomized trial in kidney transplantationAm J Transplant2012122744275322812414
- DiekmannFBuddeKOppenheimerFFritscheLNeumayerHHCampistolJMPredictors of success in conversion from calcineurin inhibitor to sirolimus in chronic allograft dysfunctionAm J Transplant200441869187515476488
- NankivellBJGruenewaldSMAllenRDChapmanJRPredicting glomerular filtration rate after kidney transplantationTransplantation199559168316897604438
- ChanLHartmannECibrikDCooperMShawLMOptimal everolimus concentration is associated with risk reduction for acute rejection in de novo renal transplant recipientsTransplantation201090313720517177
- SolezKCovinRBRacusenLCBanff 07 classification of renal allograft pathology: updates and future directionsAm J Transplant2008875376018294345
- ColvinRBCADI, Canti, CaviTransplantation20078367767817414694
- RushDProtocol transplant biopsies: an underutilized tool in kidney transplantationClin J Am Soc Nephrol2006113814317699200
- NankivellBJFenton-LeeCAKuypersDREffect of histological damage on long-term kidney transplant outcomeTransplantation20017151552311258430
- NankivellBJBorrowsRJFungCLO’ConnellPJChapmanJRAllenRDDelta analysis of posttransplantation tubulointerstitial damageTransplantation20047843444115316373
- SaurinaACampistolJMLarioSOppenheimerFDiekmannFConversion from calcineurin inhibitors to sirolimus in kidney transplant patients reduces the urinary transforming growth factor-β1 concentrationTransplant Proc2007392138214117889117
- SumethkulVChangsirikulchaiSLothuvachaiTChalermsanyakornPSirolimus attenuates the rate of progression of early chronic allograft nephropathyTransplant Proc2006383470347217175307
- LeveyASBoschJPLewisJBGreeneTRogersNRothDModification of Diet in Renal Disease Study GroupA more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equationAnn Intern Med199913046147010075613
- LevyASStevensLASchmidCHCKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)A new equation to estimate glomerular filtration rateAnn Intern Med200915060461219414839
- MoranneOMaillardNFafinCThibaudinLAlamartineEMariatCRate of renal graft function decline after one year is a strong predictor of all-cause mortalityAm J Transplant20131369570623311466
- ParkWDGriffinMDCornellLDCosioFGStegallMDFibrosis with inflammation at one year predicts transplant functional declineJ Am Soc Nephrol2010211987199720813870
- MotaAAriasMTaskinenEIRapamune Maintenance Regimen TrialSirolimus-based therapy following early cyclosporine withdrawal provides significantly improved renal histology and function at 3 yearsAm J Transplant2004495396115147430
- HoldaasHRostaingLSerónDASCERTAIN InvestigatorsConversion of long-term kidney transplant recipients from calcineurin inhibitor therapy to everolimus: a randomized, multicenter, 24-month studyTransplantation20119241041821697773
- BuddeKSommererCRathTRenal function to 5 years after late conversion of kidney transplant patients to everolimus: a randomized trialJ Nephrol Epub962014
- KasiskeBLZeierMGChapmanJRKidney Disease: Improving Global OutcomesKDIGO clinical practice guideline for the care of kidney transplant recipients: a summaryKidney Int20107729931119847156
- KurdiánMHerrero-FresnedaILloberasNDelayed mTOR inhibiton with low dose of everolimus reduces TGFβ expression, attenuates proteinuria and renal damage in the renal mass reduction modelPLoS One20127e325
- ChapmanJRChronic calcineurin inhibitor nephrotoxicity – lest we forgetAm J Transplant20111169369721446974
- IbrahimHNJacksonSConnaireJAngiotensin II blockade in kidney transplant recipientsJ Am Soc Nephrol20132432032723308016